AHL Partners LLP raised its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 17.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 24,301 shares of the medical instruments supplier’s stock after purchasing an additional 3,560 shares during the quarter. AHL Partners LLP’s holdings in West Pharmaceutical Services were worth $2,296,000 as of its most recent SEC filing.
Other large investors have also recently modified their holdings of the company. American Century Companies Inc. lifted its holdings in West Pharmaceutical Services by 0.4% during the second quarter. American Century Companies Inc. now owns 701,364 shares of the medical instruments supplier’s stock valued at $66,293,000 after purchasing an additional 2,605 shares in the last quarter. CIBC Asset Management Inc purchased a new position in West Pharmaceutical Services during the second quarter valued at approximately $223,000. State Board of Administration of Florida Retirement System lifted its holdings in West Pharmaceutical Services by 16.7% during the second quarter. State Board of Administration of Florida Retirement System now owns 88,252 shares of the medical instruments supplier’s stock valued at $8,342,000 after purchasing an additional 12,609 shares in the last quarter. Chatham Capital Group Inc. lifted its holdings in West Pharmaceutical Services by 7.8% during the second quarter. Chatham Capital Group Inc. now owns 17,300 shares of the medical instruments supplier’s stock valued at $1,635,000 after purchasing an additional 1,245 shares in the last quarter. Finally, Marshall Wace North America L.P. lifted its holdings in West Pharmaceutical Services by 17.2% during the second quarter. Marshall Wace North America L.P. now owns 145,560 shares of the medical instruments supplier’s stock valued at $13,829,000 after purchasing an additional 21,369 shares in the last quarter. 90.57% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION NOTICE: “AHL Partners LLP Has $2.30 Million Holdings in West Pharmaceutical Services, Inc. (WST)” was originally posted by Community Financial News and is owned by of Community Financial News. If you are accessing this piece of content on another site, it was copied illegally and republished in violation of United States & international copyright laws. The legal version of this piece of content can be read at https://www.com-unik.info/2017/10/13/ahl-partners-llp-has-2-30-million-holdings-in-west-pharmaceutical-services-inc-wst.html.
Several equities analysts have weighed in on WST shares. BidaskClub downgraded shares of West Pharmaceutical Services from a “hold” rating to a “sell” rating in a report on Thursday, July 27th. Zacks Investment Research raised shares of West Pharmaceutical Services from a “sell” rating to a “hold” rating in a report on Wednesday, September 27th. Jefferies Group LLC raised shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating and lifted their price target for the company from $96.00 to $115.00 in a report on Friday, September 15th. Finally, Stephens started coverage on shares of West Pharmaceutical Services in a report on Tuesday, October 3rd. They set an “equal weight” rating and a $99.00 price target on the stock. One investment analyst has rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $107.00.
West Pharmaceutical Services (NYSE:WST) last issued its quarterly earnings data on Thursday, July 27th. The medical instruments supplier reported $0.66 EPS for the quarter, topping analysts’ consensus estimates of $0.65 by $0.01. The business had revenue of $397.60 million for the quarter, compared to analysts’ expectations of $406.00 million. West Pharmaceutical Services had a net margin of 11.42% and a return on equity of 14.02%. The business’s revenue was up 2.5% on a year-over-year basis. During the same quarter last year, the company earned $0.59 EPS.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 1st. Stockholders of record on Wednesday, October 18th will be paid a dividend of $0.14 per share. This is a boost from West Pharmaceutical Services’s previous quarterly dividend of $0.13. The ex-dividend date of this dividend is Tuesday, October 17th. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.59%. West Pharmaceutical Services’s dividend payout ratio (DPR) is presently 22.22%.
West Pharmaceutical Services Company Profile
West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.
What are top analysts saying about West Pharmaceutical Services Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for West Pharmaceutical Services Inc. and related companies.